The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD
This process, combined with the increase in lean muscle mass, creates a more efficient metabolic state
Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial
NKT and MAIT cells are also involved in the immune response, with NKT cells contributing to liver inflammation and MAIT cells, although typically protective against bacterial infections, becoming depleted and dysfunctional in ALD
It helps the liver by making you thinner
No downtime is required, and any mild discomfort is temporary